$AVTR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Avantor, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Avantor, Inc.. Get notifications about new insider transactions in Avantor, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 26 2021 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Sell | S | 31.57 | 157,571 | 4,974,516 | 506,218 | 663.8 K to 506.2 K (-23.74 %) |
May 26 2021 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Sell | S | 31.74 | 180,000 | 5,713,200 | 663,789 | 843.8 K to 663.8 K (-21.33 %) |
May 19 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 30.90 | 19,683 | 608,205 | 168,982 | 188.7 K to 169 K (-10.43 %) |
May 13 2021 | AVTR | Avantor, Inc. | Natauri Jo | Director | Buy | J | 30.86 | 92,661 | 2,859,518 | 92,661 | 0 to 92.7 K |
May 13 2021 | AVTR | Avantor, Inc. | Natauri Jo | Director | Sell | J | 30.86 | 24,729,495 | 763,152,216 | 175,625 | 24.9 M to 175.6 K (-99.29 %) |
May 13 2021 | AVTR | Avantor, Inc. | Natauri Jo | Director | Sell | S | 30.68 | 2,626,771 | 80,589,334 | 24,807,518 | 27.4 M to 24.8 M (-9.57 %) |
May 04 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | M | 23.21 | 53,649 | 1,245,193 | 487,181 | |
May 04 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Sell | S | 32.58 | 53,649 | 1,747,884 | 155,888 | 209.5 K to 155.9 K (-25.60 %) |
May 04 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Buy | M | 23.21 | 53,649 | 1,245,193 | 209,537 | 155.9 K to 209.5 K (+34.42 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | M | 1.60 | 100,160 | 160,256 | 0 | |
Apr 13 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Sell | S | 32.37 | 100,160 | 3,242,179 | 155,888 | 256 K to 155.9 K (-39.12 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Buy | M | 1.60 | 100,160 | 160,256 | 256,048 | 155.9 K to 256 K (+64.25 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Sell | S | 31.83 | 17,075 | 543,497 | 216,594 | 233.7 K to 216.6 K (-7.31 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Sell | S | 31.75 | 10,000 | 317,500 | 233,669 | 243.7 K to 233.7 K (-4.10 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Sell | S | 32.00 | 2,505 | 80,160 | 118,136 | 120.6 K to 118.1 K (-2.08 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Option Exercise | M | 23.21 | 100,000 | 2,321,000 | 305,625 | |
Apr 13 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Sell | S | 33.21 | 100,000 | 3,321,000 | 118,679 | 218.7 K to 118.7 K (-45.73 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Buy | M | 23.21 | 100,000 | 2,321,000 | 218,679 | 118.7 K to 218.7 K (+84.26 %) |
Apr 13 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Sell | S | 31.75 | 2,895 | 91,916 | 118,679 | 121.6 K to 118.7 K (-2.38 %) |
Apr 07 2021 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, AMEA | Grant | A | 0.00 | 8,267 | 0 | 177,459 | 169.2 K to 177.5 K (+4.89 %) |
Mar 10 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Sell | S | 28.21 | 10,000 | 282,100 | 243,669 | 253.7 K to 243.7 K (-3.94 %) |
Mar 03 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Sell | S | 28.71 | 3,036 | 87,164 | 145,438 | 148.5 K to 145.4 K (-2.04 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Peacock Jonathan M | Director | Grant | A | 0.00 | 7,236 | 0 | 168,431 | 161.2 K to 168.4 K (+4.49 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Andres Juan | Director | Grant | A | 0.00 | 7,236 | 0 | 22,187 | 15 K to 22.2 K (+48.40 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | SUMME GREGORY L | Director | Grant | A | 0.00 | 7,236 | 0 | 14,818 | 7.6 K to 14.8 K (+95.44 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Shaw Christi | Director | Grant | A | 0.00 | 7,236 | 0 | 18,555 | 11.3 K to 18.6 K (+63.93 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Grant | A | 0.00 | 7,236 | 0 | 1,447,952 | 1.4 M to 1.4 M (+0.50 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Lewis Sheri | EVP, Global Ops & S ... | Option Exercise | A | 27.64 | 43,911 | 1,213,700 | 43,911 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Lewis Sheri | EVP, Global Ops & S ... | Grant | A | 0.00 | 13,567 | 0 | 66,856 | 53.3 K to 66.9 K (+25.46 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Director | Grant | A | 0.00 | 7,236 | 0 | 17,258 | 10 K to 17.3 K (+72.20 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Henrichwark Sven | EVP, APAC Region | Option Exercise | A | 27.64 | 17,564 | 485,469 | 17,564 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Henrichwark Sven | EVP, APAC Region | Grant | A | 0.00 | 5,427 | 0 | 19,802 | 14.4 K to 19.8 K (+37.75 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, Services | Option Exercise | A | 27.64 | 21,956 | 606,864 | 21,956 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, Services | Grant | A | 0.00 | 6,784 | 0 | 169,192 | 162.4 K to 169.2 K (+4.18 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Option Exercise | A | 27.64 | 17,564 | 485,469 | 17,564 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Grant | A | 0.00 | 5,427 | 0 | 120,641 | 115.2 K to 120.6 K (+4.71 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | A | 27.64 | 17,564 | 485,469 | 17,564 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Grant | A | 0.00 | 5,427 | 0 | 155,888 | 150.5 K to 155.9 K (+3.61 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Henson Meghan | EVP, Chief HR Offic ... | Option Exercise | A | 27.64 | 26,347 | 728,231 | 26,347 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Henson Meghan | EVP, Chief HR Offic ... | Grant | A | 0.00 | 8,140 | 0 | 25,902 | 17.8 K to 25.9 K (+45.83 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Szlosek Thomas A | EVP & CFO | Option Exercise | A | 27.64 | 52,693 | 1,456,435 | 52,693 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Szlosek Thomas A | EVP & CFO | Grant | A | 0.00 | 16,281 | 0 | 272,655 | 256.4 K to 272.7 K (+6.35 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Option Exercise | A | 27.64 | 26,347 | 728,231 | 26,347 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Grant | A | 0.00 | 8,140 | 0 | 121,574 | 113.4 K to 121.6 K (+7.18 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Option Exercise | A | 27.64 | 26,347 | 728,231 | 26,347 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Grant | A | 0.00 | 8,140 | 0 | 148,474 | 140.3 K to 148.5 K (+5.80 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Option Exercise | A | 27.64 | 52,693 | 1,456,435 | 52,693 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Grant | A | 0.00 | 16,281 | 0 | 253,669 | 237.4 K to 253.7 K (+6.86 %) |
Mar 01 2021 | AVTR | Avantor, Inc. | Murray Mark Christopher | EVP, Biomaterials & ... | Option Exercise | A | 27.64 | 26,347 | 728,231 | 26,347 | |
Mar 01 2021 | AVTR | Avantor, Inc. | Murray Mark Christopher | EVP, Biomaterials & ... | Grant | A | 0.00 | 8,140 | 0 | 19,598 | 11.5 K to 19.6 K (+71.04 %) |
Feb 26 2021 | AVTR | Avantor, Inc. | Eck Steven W | SVP & Chief Account ... | Payment of Exercise | F | 27.94 | 2,577 | 72,001 | 25,955 | 28.5 K to 26 K (-9.03 %) |
Feb 26 2021 | AVTR | Avantor, Inc. | Eck Steven W | SVP & Chief Account ... | Buy | M | 0.00 | 8,550 | 0 | 28,532 | 20 K to 28.5 K (+42.79 %) |
Feb 26 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 27.93 | 3,059 | 85,438 | 172,384 | 175.4 K to 172.4 K (-1.74 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | M | 17.67 | 19,769 | 349,318 | 59,306 | |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 28.62 | 19,769 | 565,789 | 175,443 | 195.2 K to 175.4 K (-10.13 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 17.67 | 19,769 | 349,318 | 195,212 | 175.4 K to 195.2 K (+11.27 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 28.69 | 3,072 | 88,136 | 175,443 | 178.5 K to 175.4 K (-1.72 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, Services | Payment of Exercise | F | 28.69 | 1,313 | 37,670 | 162,408 | 163.7 K to 162.4 K (-0.80 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Payment of Exercise | F | 28.69 | 1,209 | 34,686 | 140,334 | 141.5 K to 140.3 K (-0.85 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Payment of Exercise | F | 28.69 | 1,350 | 38,732 | 113,434 | 114.8 K to 113.4 K (-1.18 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Eck Steven W | SVP & Chief Account ... | Payment of Exercise | F | 28.69 | 449 | 12,882 | 19,982 | 20.4 K to 20 K (-2.20 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Payment of Exercise | F | 28.69 | 398 | 11,419 | 237,388 | 237.8 K to 237.4 K (-0.17 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Payment of Exercise | F | 28.69 | 10,141 | 290,945 | 1,437,122 | 1.4 M to 1.4 M (-0.70 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Payment of Exercise | F | 28.69 | 1,216 | 34,887 | 115,214 | 116.4 K to 115.2 K (-1.04 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Payment of Exercise | F | 28.69 | 1,210 | 34,715 | 150,461 | 151.7 K to 150.5 K (-0.80 %) |
Feb 23 2021 | AVTR | Avantor, Inc. | Szlosek Thomas A | EVP & CFO | Payment of Exercise | F | 28.69 | 2,980 | 85,496 | 256,374 | 259.4 K to 256.4 K (-1.15 %) |
Feb 08 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Option Exercise | M | 23.20 | 40,000 | 928,000 | 230,415 | |
Feb 08 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Sell | S | 29.77 | 40,000 | 1,190,800 | 141,543 | 181.5 K to 141.5 K (-22.03 %) |
Feb 08 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Buy | M | 23.20 | 40,000 | 928,000 | 181,543 | 141.5 K to 181.5 K (+28.26 %) |
Feb 08 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Sell | S | 29.77 | 9,468 | 281,862 | 141,543 | 151 K to 141.5 K (-6.27 %) |
Jan 15 2021 | AVTR | Avantor, Inc. | Murray Mark Christopher | EVP, Biomaterials & ... | Payment of Exercise | F | 29.20 | 918 | 26,806 | 11,458 | 12.4 K to 11.5 K (-7.42 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Sell | S | 30.00 | 2,505 | 75,150 | 116,430 | 118.9 K to 116.4 K (-2.11 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | M | 23.21 | 162,248 | 3,765,776 | 162,250 | |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 30.04 | 162,248 | 4,873,930 | 178,515 | 340.8 K to 178.5 K (-47.61 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 23.20 | 162,248 | 3,764,154 | 340,763 | 178.5 K to 340.8 K (+90.89 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 30.08 | 216,332 | 6,507,267 | 178,515 | 394.8 K to 178.5 K (-54.79 %) |
Jan 13 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 23.20 | 216,332 | 5,018,902 | 394,847 | 178.5 K to 394.8 K (+121.18 %) |
Jan 08 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 27.24 | 11,509 | 313,505 | 178,515 | 190 K to 178.5 K (-6.06 %) |
Jan 07 2021 | AVTR | Avantor, Inc. | Henson Meghan | EVP, Chief HR Offic ... | Option Exercise | A | 28.15 | 177,305 | 4,991,136 | 177,305 | |
Jan 07 2021 | AVTR | Avantor, Inc. | Henson Meghan | EVP, Chief HR Offic ... | Grant | A | 0.00 | 17,762 | 0 | 17,762 | 0 to 17.8 K |
Jan 07 2021 | AVTR | Avantor, Inc. | Lewis Sheri | EVP, Global Ops & S ... | Option Exercise | A | 28.15 | 59,102 | 1,663,721 | 59,102 | |
Jan 07 2021 | AVTR | Avantor, Inc. | Lewis Sheri | EVP, Global Ops & S ... | Grant | A | 0.00 | 53,286 | 0 | 53,286 | 0 to 53.3 K |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Option Exercise | M | 18.45 | 59,418 | 1,096,262 | 118,835 | |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 27.84 | 59,418 | 1,654,197 | 190,024 | 249.4 K to 190 K (-23.82 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Buy | M | 18.45 | 59,418 | 1,096,262 | 249,442 | 190 K to 249.4 K (+31.27 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 28.15 | 6,559 | 184,636 | 190,024 | 196.6 K to 190 K (-3.34 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Szlosek Thomas A | EVP & CFO | Payment of Exercise | F | 28.15 | 8,135 | 229,000 | 257,999 | 266.1 K to 258 K (-3.06 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Payment of Exercise | F | 28.15 | 1,017 | 28,629 | 236,414 | 237.4 K to 236.4 K (-0.43 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Payment of Exercise | F | 28.15 | 4,083 | 114,936 | 149,974 | 154.1 K to 150 K (-2.65 %) |
Jan 06 2021 | AVTR | Avantor, Inc. | Eck Steven W | SVP & Chief Account ... | Payment of Exercise | F | 28.15 | 3,052 | 85,914 | 20,431 | 23.5 K to 20.4 K (-13.00 %) |
Dec 23 2020 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Sell | S | 27.14 | 10,020 | 271,943 | 117,768 | 127.8 K to 117.8 K (-7.84 %) |
Dec 15 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Gift | G | 0.00 | 400,000 | 0 | 400,000 | 0 to 400 K |
Dec 15 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Gift | G | 0.00 | 400,000 | 0 | 1,447,265 | 1.8 M to 1.4 M (-21.65 %) |
Dec 15 2020 | AVTR | Avantor, Inc. | Shaw Christi | Director | Sell | S | 26.68 | 14,286 | 381,150 | 11,319 | 25.6 K to 11.3 K (-55.79 %) |
Dec 08 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Option Exercise | M | 1.60 | 201,369 | 322,190 | 0 | |
Dec 08 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Option Exercise | M | 1.60 | 880,601 | 1,408,962 | 201,369 | |
Dec 08 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Sell | S | 27.45 | 98,452 | 2,702,507 | 1,847,265 | 1.9 M to 1.8 M (-5.06 %) |
Dec 08 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Buy | M | 1.60 | 210,369 | 336,590 | 1,945,717 | 1.7 M to 1.9 M (+12.12 %) |
Dec 08 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Sell | S | 27.08 | 412,188 | 11,162,051 | 1,735,348 | 2.1 M to 1.7 M (-19.19 %) |
Dec 08 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | President and CEO | Buy | M | 1.60 | 880,601 | 1,408,962 | 2,147,536 | 1.3 M to 2.1 M (+69.51 %) |
Sep 17 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | M | 1.60 | 35,000 | 56,000 | 18,440 | |
Sep 17 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Sell | S | 23.02 | 35,000 | 805,700 | 151,671 | 186.7 K to 151.7 K (-18.75 %) |
Sep 17 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Buy | M | 1.60 | 35,000 | 56,000 | 186,671 | 151.7 K to 186.7 K (+23.08 %) |
Sep 09 2020 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Sell | S | 21.17 | 22,887 | 484,518 | 113,507 | 136.4 K to 113.5 K (-16.78 %) |
Sep 09 2020 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Sell | S | 21.17 | 22,887 | 484,518 | 113,507 | 136.4 K to 113.5 K (-16.78 %) |
Aug 25 2020 | AVTR | Avantor, Inc. | Natauri Jo | Sell | S | 19.51 | 15,397,005 | 300,341,678 | 43,483,708 | 58.9 M to 43.5 M (-26.15 %) | |
Aug 25 2020 | AVTR | Avantor, Inc. | GOLDMAN SACHS & CO. LLC | Sell | S | 19.51 | 15,397,005 | 300,341,678 | 43,483,708 | 58.9 M to 43.5 M (-26.15 %) | |
Aug 25 2020 | AVTR | Avantor, Inc. | New Mountain Investments III, ... | 10% Owner | Sell | S | 19.51 | 25,575,472 | 498,887,945 | 64,016,093 | 89.6 M to 64 M (-28.55 %) |
Aug 19 2020 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Option Exercise | M | 1.60 | 430,325 | 688,520 | 0 | |
Aug 19 2020 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Option Exercise | M | 1.60 | 717,645 | 1,148,232 | 0 | |
Aug 19 2020 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Gift | G | 0.00 | 100,000 | 0 | 1,756,716 | 1.9 M to 1.8 M (-5.39 %) |
Aug 19 2020 | AVTR | Avantor, Inc. | GUPTA RAJIV | Director | Buy | M | 1.60 | 1,147,970 | 1,836,752 | 1,856,716 | 708.7 K to 1.9 M (+161.97 %) |
Aug 03 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | M | 1.60 | 35,000 | 56,000 | 53,440 | |
Aug 03 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Sell | S | 21.37 | 35,000 | 747,950 | 151,671 | 186.7 K to 151.7 K (-18.75 %) |
Aug 03 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Buy | M | 1.60 | 35,000 | 56,000 | 186,671 | 151.7 K to 186.7 K (+23.08 %) |
Jun 02 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | M | 1.60 | 35,000 | 56,000 | 88,440 | |
Jun 02 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Option Exercise | M | 1.60 | 30,000 | 48,000 | 185,160 | |
Jun 02 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Sell | S | 19.07 | 35,000 | 667,450 | 151,671 | 186.7 K to 151.7 K (-18.75 %) |
Jun 02 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Buy | M | 1.60 | 35,000 | 56,000 | 186,671 | 151.7 K to 186.7 K (+23.08 %) |
Jun 02 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Sell | S | 18.57 | 30,000 | 557,100 | 151,671 | 181.7 K to 151.7 K (-16.51 %) |
Jun 02 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Buy | M | 1.60 | 30,000 | 48,000 | 181,671 | 151.7 K to 181.7 K (+19.78 %) |
May 28 2020 | AVTR | Avantor, Inc. | New Mountain Investments III, ... | 10% Owner | Sell | S | 15.90 | 20,886,424 | 332,192,308 | 89,591,565 | 110.5 M to 89.6 M (-18.91 %) |
May 28 2020 | AVTR | Avantor, Inc. | Natauri Jo | Option Exercise | X | 0.00 | 1,133,920 | 2,268 | 0 | ||
May 28 2020 | AVTR | Avantor, Inc. | Natauri Jo | Sell | S | 15.90 | 13,726,411 | 218,249,935 | 58,881,710 | 72.6 M to 58.9 M (-18.90 %) | |
May 28 2020 | AVTR | Avantor, Inc. | Natauri Jo | Buy | X | 0.00 | 1,133,920 | 2,268 | 72,605,349 | 71.5 M to 72.6 M (+1.59 %) | |
May 28 2020 | AVTR | Avantor, Inc. | Connolly Thomas | Option Exercise | X | 0.00 | 1,133,920 | 2,268 | 0 | ||
May 28 2020 | AVTR | Avantor, Inc. | Connolly Thomas | Sell | S | 15.90 | 13,726,411 | 218,249,935 | 58,881,710 | 72.6 M to 58.9 M (-18.90 %) | |
May 28 2020 | AVTR | Avantor, Inc. | Connolly Thomas | Buy | X | 0.00 | 1,133,920 | 2,268 | 72,605,349 | 71.5 M to 72.6 M (+1.59 %) | |
May 28 2020 | AVTR | Avantor, Inc. | GOLDMAN SACHS & CO. LLC | Option Exercise | X | 0.00 | 1,133,920 | 2,268 | 0 | ||
May 28 2020 | AVTR | Avantor, Inc. | GOLDMAN SACHS & CO. LLC | Sell | S | 15.90 | 13,726,411 | 218,249,935 | 58,881,710 | 72.6 M to 58.9 M (-18.90 %) | |
May 28 2020 | AVTR | Avantor, Inc. | GOLDMAN SACHS & CO. LLC | Buy | X | 0.00 | 1,133,920 | 2,268 | 72,605,349 | 71.5 M to 72.6 M (+1.59 %) | |
May 27 2020 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Sell | S | 17.82 | 22,987 | 409,628 | 154,087 | 177.1 K to 154.1 K (-12.98 %) |
May 22 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Sell | S | 17.36 | 25,495 | 442,593 | 196,583 | 222.1 K to 196.6 K (-11.48 %) |
May 19 2020 | AVTR | Avantor, Inc. | Szlosek Thomas A | EVP & CFO | Payment of Exercise | F | 17.86 | 21,287 | 380,186 | 266,134 | 287.4 K to 266.1 K (-7.41 %) |
May 19 2020 | AVTR | Avantor, Inc. | Wondrasch Michael | EVP & CIO | Payment of Exercise | F | 17.86 | 9,155 | 163,508 | 177,044 | 186.2 K to 177 K (-4.92 %) |
May 19 2020 | AVTR | Avantor, Inc. | Brophy Gerard | EVP, Biopharma Prod ... | Payment of Exercise | F | 17.86 | 13,790 | 246,289 | 222,078 | 235.9 K to 222.1 K (-5.85 %) |
May 19 2020 | AVTR | Avantor, Inc. | Couturier Christophe | EVP, Services | Payment of Exercise | F | 17.86 | 11,189 | 199,836 | 162,932 | 174.1 K to 162.9 K (-6.43 %) |
May 19 2020 | AVTR | Avantor, Inc. | Vanderhaegen Frederic | EVP, Europe | Payment of Exercise | F | 17.86 | 2,210 | 39,471 | 237,431 | 239.6 K to 237.4 K (-0.92 %) |
May 19 2020 | AVTR | Avantor, Inc. | Miller Justin | EVP & General Couns ... | Payment of Exercise | F | 17.86 | 9,155 | 163,508 | 136,394 | 145.5 K to 136.4 K (-6.29 %) |
May 19 2020 | AVTR | Avantor, Inc. | Ohri Devashish | EVP, IMEA | Payment of Exercise | F | 17.86 | 16,791 | 299,887 | 151,671 | 168.5 K to 151.7 K (-9.97 %) |
May 19 2020 | AVTR | Avantor, Inc. | McAllister Eric | EVP, CHRO | Payment of Exercise | F | 17.86 | 9,155 | 163,508 | 197,899 | 207.1 K to 197.9 K (-4.42 %) |
May 19 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | CEO | Payment of Exercise | F | 17.86 | 108,700 | 1,941,382 | 1,266,935 | 1.4 M to 1.3 M (-7.90 %) |
May 19 2020 | AVTR | Avantor, Inc. | Bramwell James | EVP, Strategic Part ... | Payment of Exercise | F | 17.86 | 12,102 | 216,142 | 127,788 | 139.9 K to 127.8 K (-8.65 %) |
May 19 2020 | AVTR | Avantor, Inc. | Eck Steven W | SVP & Chief Account ... | Payment of Exercise | F | 17.86 | 573 | 10,234 | 23,483 | 24.1 K to 23.5 K (-2.38 %) |
May 12 2020 | AVTR | Avantor, Inc. | SUMME GREGORY L | Director | Grant | A | 0.00 | 7,582 | 0 | 7,582 | 0 to 7.6 K |
May 12 2020 | AVTR | Avantor, Inc. | McAllister Eric | EVP, CHRO | Payment of Exercise | F | 14.04 | 8,975 | 126,009 | 207,054 | 216 K to 207.1 K (-4.15 %) |
Apr 24 2020 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Director | Grant | A | 0.00 | 10,022 | 0 | 10,022 | 0 to 10 K |
Apr 24 2020 | AVTR | Avantor, Inc. | SEVERINO MICHAEL | Director | Grant | A | 0.00 | 10,022 | 0 | 10,022 | 0 to 10 K |
Mar 13 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | CEO | Option Exercise | M | 1.60 | 200,000 | 320,000 | 1,090,970 | |
Mar 13 2020 | AVTR | Avantor, Inc. | Stubblefield Michael | CEO | Buy | M | 1.60 | 200,000 | 320,000 | 1,375,635 | 1.2 M to 1.4 M (+17.01 %) |